BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence (“AI”) to develop transformative medicines in neuroscience, today announced the presentation of ...
Baron Global Durable Advantage ETF declined 7.3% (NAV) during the first quarter, compared to the 3.2% decline for the MSCI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results